SCI-TIF community gathers for 3rd Annual Networking Dinner
29 April 2025
Last week, the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) celebrated its 3rd Annual Networking Dinner at Homerton College, Cambridge. This event brought together leading scientists from academia and industry, reinforcing SCI-TIF’s mission to unite the Cambridge stem cell community and foster...
Professor Sarah Teichmann announced as new member of the American Academy of Arts & Sciences
24 April 2025
Professor Sarah Teichmann FMedSci FRS, Chair in Stem Cell Medicine at the University of Cambridge (Cambridge Stem Cell Institute & Dept Medicine), and Group Leader at CSCI, has been announced this week as one of the newest members of the prestigious American Academy of Arts & Sciences . Sarah says, “ It is a...
Groundbreaking discovery from Tzelepis Lab could revolutionise treatment for deadly blood cancers
23 April 2025
A new study from Dr Konstantinos Tzelepis at the Cambridge Stem Cell Institute has discovered a new way to detect and target Acute Myeloid Leukaemia (AML), a fast growing, aggressive, blood cancer that requires urgent treatment. The research was published today (23 April) in Nature Biotechnology. AML is the second most...
New research from Vassiliou Group shows diabetes drug may prevent aggressive leukaemia
17 April 2025
Research out this week from the Vassiliou and Huntly Groups shows that a common diabetes drug could prevent a form of acute myeloid leukaemia in people at high risk of the disease. The research, published 16 April in Nature , found that metformin, a widely used and readily available diabetes drug, could prevent abnormal...